Warfarin acts by –
**Core Concept**
Warfarin is an anticoagulant medication that inhibits vitamin K-dependent clotting factors, thereby prolonging the coagulation cascade and reducing the risk of thrombosis.
**Why the Correct Answer is Right**
Warfarin specifically inhibits the vitamin K-dependent gamma-carboxylation of clotting factors II, VII, IX, and X. This process is essential for the activation of these clotting factors, which are then involved in the coagulation cascade. By inhibiting this gamma-carboxylation, warfarin effectively reduces the production of these clotting factors, leading to a decrease in thrombin generation and a subsequent decrease in blood clot formation. This mechanism is responsible for warfarin's anticoagulant effects.
**Why Each Wrong Option is Incorrect**
**Option A:** This is incorrect because while warfarin does affect the coagulation cascade, it does not primarily act through inhibition of tissue factor or factor VIIa.
**Option B:** This is incorrect because warfarin does not primarily act through inhibition of platelet aggregation, which is a different mechanism of action.
**Option C:** This is incorrect because warfarin does not primarily act through inhibition of fibrinolysis, which is the breakdown of blood clots.
**Clinical Pearl / High-Yield Fact**
Warfarin's anticoagulant effects can be reversed with vitamin K administration, which replenishes the necessary cofactors for the gamma-carboxylation of clotting factors. However, this reversal process can take several hours, highlighting the importance of careful monitoring of coagulation parameters in patients on warfarin therapy.
**Correct Answer:** D. Inhibition of vitamin K-dependent gamma-carboxylation of clotting factors II, VII, IX, and X.